ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 115 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,844,920 | -10.6% | 228,764 | +0.4% | 0.00% | 0.0% |
| Q2 2023 | $6,534,853 | +28.5% | 227,854 | +7.4% | 0.00% | 0.0% |
| Q1 2023 | $5,085,763 | +40.6% | 212,172 | -0.5% | 0.00% | 0.0% |
| Q4 2022 | $3,616,856 | +17.7% | 213,258 | +2.8% | 0.00% | 0.0% |
| Q3 2022 | $3,074,000 | -6.5% | 207,395 | -0.7% | 0.00% | 0.0% |
| Q2 2022 | $3,288,000 | -37.0% | 208,896 | +7.8% | 0.00% | 0.0% |
| Q1 2022 | $5,223,000 | -30.2% | 193,709 | -4.2% | 0.00% | 0.0% |
| Q4 2021 | $7,481,000 | -23.7% | 202,152 | -1.5% | 0.00% | -50.0% |
| Q3 2021 | $9,808,000 | +22.8% | 205,270 | -13.0% | 0.00% | +100.0% |
| Q2 2021 | $7,988,000 | -20.8% | 236,039 | -3.4% | 0.00% | -50.0% |
| Q1 2021 | $10,090,000 | -18.8% | 244,298 | -14.7% | 0.00% | 0.0% |
| Q4 2020 | $12,422,000 | +19.2% | 286,372 | +17.9% | 0.00% | 0.0% |
| Q3 2020 | $10,421,000 | +3.7% | 242,915 | +13.0% | 0.00% | 0.0% |
| Q2 2020 | $10,046,000 | +1869.8% | 214,923 | +472.2% | 0.00% | – |
| Q1 2020 | $510,000 | +28.1% | 37,560 | +2.5% | 0.00% | – |
| Q4 2019 | $398,000 | +70.8% | 36,630 | +61.1% | 0.00% | – |
| Q3 2019 | $233,000 | – | 22,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
| DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
| One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
| Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
| ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
| EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
| Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
| MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
| Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |